Bayer China -Homepage

    Local News
    
    2009-06-18
    The First Oral Factor Xa Inhibitor Xarelto® Launched in China
    Bayer HealthCare announced today that its novel anticoagulant Xarelto® (rivaroxaban) has been granted approval from the State Food and Drug Administration (SFDA) of China
    » more
    2009-06-05
    Bayer China Launches “Country Carbon Footprint” Project, Pioneering CO2 Emissions Control in the Chemical and Pharmaceutical Industry
    In conjunction with the “World Environment Day”, Bayer China launched its nation-wide “Country Carbon Footprint” program recently, recording and auditing all the Carbon emissions produced during the production and business activities.
    » more
    Bayer Global News
    About Bayer
    Bayer Schering Pharma to invest 100 million Euro in China to build a global R&D center
    Bayer HealthCare, announced that it will be strengthening its global Research and Development capabilities through the foundation of a global R&D center in Beijing, China.
    » more
     
    Products
    BMS in China
    Bayer significantly strengthens its presence in China; Startup of 350,000 tons/year MDI train; Groundbreaking for 250,000 tons/year TDI plant; Isocyanate production also to be expanded in Europe in the medium term;
    » more
     
    Press
    Bayer Cares Project
    Bayer Group, together with the Beijing Fuping Development Institute, hosted a Bayer Cares Project – Employee Volunteer Program Seminar in Jiangyou
    » more
     
    Sustainability & Commitment
    2007 Sustainability Report
    Presentation of new Sustainable Development Report in Berlin. Bayer Climate Program makes great advances Bayer is reaffirming its commitment to sustainable development.
    » more
    top
    top
    top
    top
    top
    top
    top
    top
    top
    
    Search
    Publication
    Seite verkleinern Normalansicht Seite vergrößern